These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2990721)

  • 1. Endorphin patterns within the headache spectrum disorders.
    Nappi G; Facchinetti F; Martignoni E; Petraglia F; Manzoni GC; Sances G; Sandrini G; Genazzani AR
    Cephalalgia; 1985 May; 5 Suppl 2():201-10. PubMed ID: 2990721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypernociceptive syndromes and pharmacological inhibition of endogenous opioid degradation.
    Baldi E; Conti P; Conti R; Fanciullacci M; Michelacci S; Salmon S; Sicuteri F; Spillantini MG
    Int J Clin Pharmacol Res; 1986; 6(3):193-7. PubMed ID: 2943684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary headaches: reduced circulating beta-lipotropin and beta-endorphin levels with impaired reactivity to acupuncture.
    Facchinetti F; Nappi G; Savoldi F; Genazzani AR
    Cephalalgia; 1981 Dec; 1(4):195-201. PubMed ID: 6290071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endorphin levels in headache syndromes.
    Fettes I; Gawel M; Kuzniak S; Edmeads J
    Headache; 1985 Jan; 25(1):37-9. PubMed ID: 2982765
    [No Abstract]   [Full Text] [Related]  

  • 5. Intermittent hypoendorphinaemia in migraine attack.
    Baldi E; Salmon S; Anselmi B; Spillantini MG; Cappelli G; Brocchi A; Sicuteri F
    Cephalalgia; 1982 Jun; 2(2):77-81. PubMed ID: 6290072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine evidence of deranged noradrenergic activity in chronic migraine.
    Martignoni E; Facchinetti F; Rossi F; Sances G; Genazzani AR; Nappi G
    Psychoneuroendocrinology; 1989; 14(5):357-63. PubMed ID: 2554358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian variations of proopiocortin-related peptides in children with migraine.
    Facchinetti F; D'Attoma G; Petraglia F; Pini LA; Sternieri E; Genazzani AR
    Cephalalgia; 1983 Aug; 3 Suppl 1():94-7. PubMed ID: 6311426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-endorphin and ACTH in plasma during attacks of common and classic migraine.
    Bach FW; Jensen K; Blegvad N; Fenger M; Jordal R; Olesen J
    Cephalalgia; 1985 Sep; 5(3):177-82. PubMed ID: 2994887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa.
    Kaye WH; Berrettini WH; Gwirtsman HE; Chretien M; Gold PW; George DT; Jimerson DC; Ebert MH
    Life Sci; 1987 Nov; 41(18):2147-55. PubMed ID: 2823041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The short metyrapone test in chronic headache patients.
    Szczudlik A; Lypka A
    Funct Neurol; 1986; 1(3):245-52. PubMed ID: 3038704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and CSF endorphin levels in primary and symptomatic headaches.
    Nappi G; Facchinetti F; Martignoni E; Petraglia F; Bono G; Micieli G; Rosaschino C; Manzoni GC; Genazzani AR
    Headache; 1985 May; 25(3):141-4. PubMed ID: 4008251
    [No Abstract]   [Full Text] [Related]  

  • 12. Progressive impairment of CSF beta-EP levels in migraine sufferers.
    Genazzani AR; Nappi G; Facchinetti F; Micieli G; Petraglia F; Bono G; Monittola C; Savoldi F
    Pain; 1984 Feb; 18(2):127-133. PubMed ID: 6324056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous opioids in cerebrospinal fluid and blood in idiopathic headache sufferers.
    Anselmi B; Baldi E; Casacci F; Salmon S
    Headache; 1980 Nov; 20(6):294-9. PubMed ID: 7216749
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
    Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and cerebrospinal fluid beta-endorphin in chronic tension-type headache.
    Bach FW; Langemark M; Secher NH; Olesen J
    Pain; 1992 Nov; 51(2):163-168. PubMed ID: 1484713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endorphins in the pathogenesis of headache.
    Della Bella D; Carenzi A; Casacci F; Anselmi B; Baldi E; Salmon S
    Adv Neurol; 1982; 33():75-9. PubMed ID: 6275682
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta-endorphin levels in patients with pain syndromes in the areas of the face and head].
    Puzin MN; Bassalyk LS; Kushlinskiĭ NE; Rushanov MI; Grigorian IuA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(9):69-72. PubMed ID: 2532837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central deficiency of beta-endorphin in alcohol addicts.
    Genazzani AR; Nappi G; Facchinetti F; Mazzella GL; Parrini D; Sinforiani E; Petraglia F; Savoldi F
    J Clin Endocrinol Metab; 1982 Sep; 55(3):583-6. PubMed ID: 6284787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary proopiomelanocortin peptides in mental disorders.
    Brambilla F; Petraglia F; Facchinetti F; Maggioni M; Genazzani AR
    Prog Brain Res; 1986; 65():193-206. PubMed ID: 3024224
    [No Abstract]   [Full Text] [Related]  

  • 20. Proopiomelanocortin is the predominant adrenocorticotropin-related peptide in human cerebrospinal fluid.
    Tsigos C; Crosby SR; Gibson S; Young RJ; White A
    J Clin Endocrinol Metab; 1993 Mar; 76(3):620-4. PubMed ID: 8383142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.